4 unknown, 3 completed, 2 not yet recruiting, 1 recruiting. 6 Not applicable, 5 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Not yet recruiting 2, Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 3 | 5 | Unknown 3, Completed 2 |
| Phase 2 | 4 | Unknown 3, Completed 1 |
Follow Autologous Hematopoietic Stem Cell Transplantation: new trials by email Literature Review of Autologous Hematopoietic Stem Cell Transplantation trials Research Report on Autologous Hematopoietic Stem Cell Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using Goserelin Goserelin 3.6 MG - Ovarian Insufficiency, Autologous Hematopoietic Stem Cell Transplantation | Not applicable | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 64 | 2026-05-01 | 2026-04-27 |
| Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma Hetrombopag - Delayed Platelet Engraftment, Neuroblastoma | Not applicable | Recruiting | Beijing Children's Hospital | 30 | 2024-06-30 | 2025-12-03 |
| Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma Improved BEAM regimen - Lymphoma, Autologous Hematopoietic Stem Cell Transplantation | Not applicable | Not yet recruiting | First Affiliated Hospital Xi'an Jiaotong University | 53 | 2023-01-15 | 2023-01-12 |
| Precision Dosing of Busulfan in Children Undergoing HSCT GSTA1 genotyping - Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation | Not applicable | Unknown | University Hospital, Geneva | 260 | 2021-06-15 | 2021-08-02 |
| BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT Busulfan (BU), Cyclophosphamide (CY), Etoposide (VP-16) - Primary Central Nervous System Lymphoma, Autologous Hematopoietic Stem Cell Transplantation | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 20 | 2018-11-01 | 2018-11-07 |
| Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT Busulfan (BU), Cyclophosphamide (CY), Etoposide (VP-16) - Autologous Hematopoietic Stem Cell Transplantation, Conditioning | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 122 | 2018-01-02 | 2020-02-25 |
| BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT Busulfan (BU), Cyclophosphamide (CY), Etoposide (VP-16) - Autologous Hematopoietic Stem Cell Transplantation, Diffuse Large B-cell Lymphoma | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 122 | 2017-07-05 | 2017-10-12 |
| IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT Idarubicin（IDA）, Busulfan (BU), Cyclophosphamide (CY) - Autologous Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia | Phase 2 / Phase 3 | Completed | Nanfang Hospital, Southern Medical University | 153 | 2016-01-01 | 2020-03-03 |
| Exercise in Patients Undergoing Autologous Stem Cell Transplantation: A Randomized Controlled Trial Exercise Program - Hematologic Malignacy, Autologous Hematopoietic Stem Cell Transplantation | Not applicable | Completed | TC Erciyes University | 15 | 2014-10-14 | 2026-03-09 |
| Exercise in Pediatric Autologous Stem Cell Transplant Patients EXERCISE (EX), Standard Care - Cancer, Autologous Hematopoietic Stem Cell Transplantation | Not applicable | Terminated | University of Calgary | 24 | 2012-06-01 | 2016-10-26 |
| Prevention of Left Ventricular Dysfunction During Chemotherapy Enalapril and carvedilol - Acute Myeloid Leukemia, Precursor-cell Lymphoblastic Leukemia-Lymphoma | Phase 3 | Completed | Hospital Clinic of Barcelona | 90 | 2008-04-01 | 2013-11-15 |
Leukemia, Myeloid, Acute (2) · Lymphoma (2) · Motor Activity (2) · Multiple Myeloma (2) · Lymphoma, Large B-Cell, Diffuse (1) · Neoplasms (1) · Neuroblastoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Ventricular Dysfunction (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphoproliferative Disorders (4) · Hematologic Diseases (3) · Lymphatic Diseases (3) · Behavior (2) · Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Leukemia (2) · Leukemia, Myeloid (2)
Busulfan (4) · Cyclophosphamide (4) · Etoposide (3) · Carvedilol (1) · Enalapril (1) · Exercise (1) · Goserelin (1) · Melphalan (1) · Resistance Training (1) · Standard of Care (1) · hetrombopag (1)
Nanfang Hospital, Southern Medical University (4) · Beijing Children's Hospital (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Hospital Clinic of Barcelona (1) · TC Erciyes University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · University Hospital, Geneva (1) · University of Calgary (1)
China (7) · Canada (1) · Spain (1) · Switzerland (1) · Turkey (Türkiye) (1)
Qifa Liu (3) · Nicole S Culos-Reed, Ph.D (1) · Pengcheng He, MD (1) · Xavier Bosch, M.D., PhD. (1)